Clinuvel Pharmaceuticals (ASX:CUV) strategic update fails to boost investor appetite - Sequoia Direct Pty Ltd

13AprApril 13, 2021

Clinuvel Pharmaceuticals (ASX:CUV) strategic update fails to boost investor appetite

Genetic and vascular disorder treatment company Clinuvel Pharmaceuticals (ASX:CUV) released a new strategic update on Monday.

The firm plans to expand its research capabilities for skin cancer treatments and damage remediation. The establishment of a new manufacturing division is on the company’s strategic agenda to advance new treatment formulas.

The strategic update has done little to boost investor appetite, as shares in Clinuvel Pharmaceuticals are trading 2.42 per cent lower at $29.39 .
Copyright 2021 – Finance News Network

Source: Finance News Network

Related Posts

22AprApril 22, 2020

SG Fleet Group (ASX:SGF) directors take 30% paycut

22 Apr 2020 - SG Fleet Group’s (ASX:SGF) Board of Directors and senior executives have reduced their pay by 30 per cent in efforts to manage the impact of COVID-19.

17DecDecember 17, 2020

Adbri (ASX:ABC) receives green light for Kwinana Upgrade Project

17 Dec 2020 - Adbri (ASX:ABC) have today given the ‘go ahead’ for the Kwinana Upgrade Project following a final investment decision by the Board.

18OctOctober 18, 2022

Stocks of the Hour: Arizona Lithium, Apollo Minerals, Sezzle

18 Oct 2022 - A snapshot of the stocks on the move featuring Arizona Lithium (ASX:AZL), Apollo Minerals (ASX:AON) and Sezzle (ASX:SZL).

23FebFebruary 23, 2021

Starpharma (ASX:SPL) receives EU approval for anti-COVID nasal spray

23 Feb 2021 - Pharmaceutical developer Starpharma (ASX:SPL) has received EU approval for the company’s antiviral nasal spray Viraleze.

21FebFebruary 21, 2021

Cochlear (ASX:COH) shares rise on reports of strong global growth

19 Feb 2021 - Cochlear (ASX:COH) report strong growth in the US, Japan, Korea and China, improving momentum in Western Europe and a slower recovery across most emerging markets.

19FebFebruary 19, 2020

Wesfarmers (ASX:WES) to sell 4.9% of Coles Group

19 Feb 2020 - Wesfarmers (ASX:WES) will sell 4.9 per cent of its stake in the Coles Group.

13MarMarch 13, 2020

Zip Co (ASX:Z1P) see coronavirus impact minimised by digital model

13 Mar 2020 - Zip Co (ASX:Z1P) report that they have not observed any material impact from coronavirus across its business, though they do believe there will be implications for various parts of the economy.

24SepSeptember 24, 2019

Helloworld acquires TravelEdge Group for $28 million

24 Sep 2019 - Helloworld Travel (ASX:HLO) is set to snap up Australia’s largest privately-owned corporate travel manager, the TravelEdge Group.

12OctOctober 12, 2022

Stocks of the Hour: Queensland Pacific Metals, Lake Res, Openlearning

12 Oct 2022 - A snapshot of the stocks on the move featuring Queensland Pacific Metals (ASX:QPM), Lake Resources (ASX:LKE) and Openlearning (ASX:OLL).

09OctOctober 9, 2019

Respiri (ASX:RSH) CEO Mario Gattino departs

09 Oct 2019 - Respiri (ASX:RSH) CEO Mario Gattino will be leaving the medical technology company.